Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paola Cravero
Observed names:
Cravero, Paola,
P. Cravero
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Harvard University,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center
ORCID:
0009-0003-6462-0399
Observed ORCID:
0009-0003-6462-0399
OpenAlex ID:
A5016270358
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
2019
·
Lucio Crinò
, Giuseppe Bronte
, et al.
·
Lung Cancer
·
162
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
2022
·
Matteo Canale
, Kalliopi Andrikou
, et al.
·
Cancers
·
108
PDF
Targeting RET-rearranged non-small-cell lung cancer: future prospects
2019
·
Giuseppe Bronte
, Paola Ulivi
, et al.
·
Lung Cancer Targets and Therapy
·
87
PDF
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
2021
·
A. Cortellini
, B. Ricciuti
, et al.
·
Annals of Oncology
·
72
PDF
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis
2022
·
Giuseppe Bronte
, Elisabetta Petracci
, et al.
·
Frontiers in Immunology
·
54
PDF
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
2023
·
Kalliopi Andrikou
, Tania Rossi
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin
2019
·
Serena De Matteis
, Emanuela Scarpi
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer
2019
·
Matteo Canale
, Luigi Pasini
, et al.
·
Translational Lung Cancer Research
·
27
PDF
Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection
2017
·
Manlio Monti
, Danila Diano
, et al.
·
BMC Infectious Diseases
·
20
New generation anaplastic lymphoma kinase inhibitors
2019
·
Angelo Delmonte
, Marco Angelo Burgio
, et al.
·
Translational Lung Cancer Research
·
19
PDF
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations
2022
·
Matteo Canale
, Elisabetta Petracci
, et al.
·
Translational Oncology
·
16
PDF
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience
2021
·
Paola Ulivi
, Elisabetta Petracci
, et al.
·
Biomedicines
·
16
PDF
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
2020
·
Giuseppe Bronte
, Angelo Delmonte
, et al.
·
Lung Cancer
·
13
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
2022
·
Valentina Danesi
, Ilaria Massa
, et al.
·
Cancers
·
12
PDF
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
2022
·
Paola Ulivi
, Milena Urbini
, et al.
·
Cancers
·
10
PDF
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer
2021
·
Giuseppe Bronte
, Maurizio Puccetti
, et al.
·
Frontiers in Oncology
·
10
PDF
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol
2023
·
Vanessa Valenti
, Romina Rossi
, et al.
·
BMJ Open
·
8
PDF
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
2023
·
Andrea Ambrosini-Spaltro
, Claudia Rengucci
, et al.
·
Current Oncology
·
6
Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy
2021
·
Giuseppe Bronte
, Alessandro Cafaro
, et al.
·
Expert Review of Anticancer Therapy
·
6
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
2025
·
Matteo Canale
, Alessandra Virga
, et al.
·
Lung Cancer Targets and Therapy
·
5
PDF
Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14–Mutant NSCLC
2020
·
Paola Cravero
, Nuno Vaz
, et al.
·
JTO Clinical and Research Reports
·
5
PDF
Clinical characteristics, genomic features, and recurrence risk of early-stage MET exon 14 mutant non-small cell lung cancer (NSCLC).
2020
·
Gonzalo Recondo
, Robin Guo
, et al.
·
Journal of Clinical Oncology
·
5
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival
2025
·
Matteo Canale
, Milena Urbini
, et al.
·
Lung Cancer Targets and Therapy
·
3
PDF
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer
2023
·
Alberto Verlicchi
, Matteo Canale
, et al.
·
Life
·
3
PDF
Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes
2024
·
Romina Rossi
, Paola Cravero
, et al.
·
Journal of Pain and Symptom Management
·
1
PDF
Show more works
View as search
Works count:
44
Citation count:
736
H-index:
13
I10-index:
16
Year
Topic
Type